We have advised longstanding client and early-stage VC fund Dawn Capital on its investment as part of a £110 million Series D fundraising for Quantexa. This is further investment into the data and analytics software company for Dawn Capital and follows us originally advising on the £12 million Series B funding it led for Quantexa in 2018. We also advised Dawn Capital on its participation in Quantexa's £51.2 million Series C fundraising round last July.
Dawn Capital, Europe's largest specialist B2B software investor, backs companies at series A and B and continues to fund the best performing through growth rounds to exit. We have advised Dawn Capital on numerous transactions over the last 10 years including, most recently, investments in Dataiku, Eigen Technologies, Ably, Firebolt Analytics, Tink, and Copper Technologies.
Quantexa specialises in contextual decision intelligence, using data and machine learning to help businesses make better decisions across multiple areas, including financial crime compliance, KYC, customer intelligence, fraud and credit risk.
This round was led by Warburg Pincus with participation from Dawn Capital and other existing investors Albion VC, Evolution Equity Partners, HSBC, ABN AMRO Ventures and British Patient Capital.
Commenting on the transaction, lead Partner Howard Palmer said: "Dawn Capital is committed to supporting and developing its innovative portfolio of companies, which is reflected in its latest investment in Quantexa. We are equally committed to the success of our longstanding client and look forward to supporting the team as it continues to invest in the most ground-breaking technology companies."
Henry Mason at Dawn Capital added: "We have had Taylor Wessing as our lawyers for many years and are grateful once again to the team for its exceptional work on finalising our further investment in Quantexa. The firm is quite rightly regarded as a leading advisor on venture capital in the UK and globally."
The team was led by corporate technology partner Howard Palmer and senior associate Elinor Picton.
